Variant report
Variant | esv3348869 |
---|---|
Chromosome Location | chr18:39156604-39158502 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs374577732 | chr18:39156615-39156616 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs79595982 | chr18:39156636-39156637 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs72905909 | chr18:39156686-39156687 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs537632420 | chr18:39156730-39156731 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs373818269 | chr18:39156741-39156742 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs556650281 | chr18:39156776-39156777 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs578016254 | chr18:39156865-39156866 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs539093749 | chr18:39156897-39156898 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs553765348 | chr18:39156919-39156920 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs368390665 | chr18:39156947-39156948 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs143528317 | chr18:39157022-39157023 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575252257 | chr18:39157024-39157025 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs572068047 | chr18:39157053-39157054 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs542917430 | chr18:39157078-39157079 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529103477 | chr18:39157121-39157122 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188843832 | chr18:39157128-39157129 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs542305688 | chr18:39157182-39157183 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs192881885 | chr18:39157184-39157185 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs543640926 | chr18:39157202-39157203 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs142680649 | chr18:39157268-39157269 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566517939 | chr18:39157281-39157282 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200788508 | chr18:39157292-39157293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs185819807 | chr18:39157303-39157304 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs572490543 | chr18:39157313-39157314 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572437652 | chr18:39157327-39157328 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs112593116 | chr18:39157336-39157337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs202235119 | chr18:39157337-39157338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs529130871 | chr18:39157367-39157368 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs370663446 | chr18:39157383-39157384 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs374117486 | chr18:39157405-39157406 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs377318404 | chr18:39157429-39157430 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545240056 | chr18:39157438-39157439 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs71174059 | chr18:39157515-39157516 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs187799468 | chr18:39157534-39157535 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs370372822 | chr18:39157537-39157538 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs112607504 | chr18:39157558-39157559 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs533796393 | chr18:39157560-39157561 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs113810139 | chr18:39157561-39157562 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs532908748 | chr18:39157575-39157576 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs551469271 | chr18:39157580-39157581 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs560203458 | chr18:39157602-39157603 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs527272172 | chr18:39157650-39157651 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs549336175 | chr18:39157654-39157655 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs371401228 | chr18:39157733-39157734 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs72905911 | chr18:39157801-39157802 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs78320203 | chr18:39157802-39157803 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs142707207 | chr18:39157815-39157816 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs533629848 | chr18:39157832-39157833 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs34342846 | chr18:39157842-39157843 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs192421370 | chr18:39157904-39157905 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Trisomy 18 syndrome | 17576883 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Multiple myeloma | 17550852 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
18q deletion syndrome | 19533772 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Colorectal cancer | 21102417 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Pancreatic cancer | 21811562 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Mucosa-associated lymphoid tissue lymphomas | 21459788 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21785460 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Prostate cancer | 16573809 | CNVD |
Autism | 16446308 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17603634 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
Colorectal cancer | 19150955 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Lung cancer | 18438408 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 22241247 | CNVD |
Seminomas | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Breast cancer | 17133270 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr18:39139000-39156800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
2 | chr18:39150400-39161400 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
3 | chr18:39154400-39158200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
4 | chr18:39154800-39157200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr18:39155800-39156800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
6 | chr18:39155800-39157800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr18:39155800-39158200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr18:39156000-39157200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr18:39156400-39157000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr18:39156600-39158400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr18:39156800-39157200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
12 | chr18:39156800-39157200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
13 | chr18:39157600-39160000 | Enhancers | Liver | Liver |
14 | chr18:39157800-39159200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr18:39158000-39159000 | Enhancers | Fetal Heart | heart |
16 | chr18:39158200-39159400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
17 | chr18:39158200-39160600 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
18 | chr18:39158400-39158800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |